Insiders Buying Westlake Chemical Partners And 2 Other Stocks
Insiders Buying Westlake Chemical Partners And 2 Other Stocks
Although U.S. stocks closed mostly lower on Monday, there were a few notable insider trades.
儘管週一美國股市收盤大多走低，但仍有一些值得注意的內幕交易。
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
當內部人士購買股票時，這表明他們對公司前景充滿信心，或者他們認爲股票很划算。無論哪種方式，這都預示着做多該股的機會。不應將內幕購買視爲做出投資或交易決策的唯一指標。充其量，它可以爲購買決定提供信心。
Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.
以下是最近一些值得注意的內幕收購。欲了解更多，請查看 本辛加的內幕交易 平台。
Sow Good
太棒了
- The Trade: Sow Good Inc. (OTC:SOWG) Director Lyle Berman acquired a total of 68,966 shares an average price of $7.25. To acquire these shares, it cost around $500,004.
- What's Happening: On March 28, Sow Good announced a $3.7 million private placement.
- What Sow Good Does: Sow Good Inc is engaged in manufacturing and marketing freeze-dried fruits, vegetables, snacks, smoothies, and soups.
- 交易：Sow Good Inc.（場外交易代碼：SOWG）董事萊爾·伯曼 共收購了68,966股股票 平均價格爲7.25美元。收購這些股票的成本約爲500,004美元。
- 發生了什麼：3月28日，Sow Good宣佈了370萬澳元的私募配售。
- Sow Good 能做什麼：Sow Good Inc從事凍幹水果、蔬菜、零食、冰沙和湯的生產和銷售。
Oncternal Therapeutics
內科療法
- The Trade: Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Director Robert James Wills acquired a total of 6,914 shares at an average price of $8.48. To acquire these shares, it cost around $58,602.
- What's Happening: On March 7, Oncternal Therapeutics posted upbeat quarterly sales.
- What Oncternal Therapeutics Does: Oncternal Therapeutics Inc is a clinical-stage oncology company developing first-in-class, novel therapies that target a broad spectrum of cancers with a large unmet medical need.
- 交易：Oncternal Therapeutics, Inc.（納斯達克股票代碼：ONCT）董事羅伯特·詹姆斯·威爾斯共收購了6,914股股票，平均價格爲8.48美元。收購這些股票的成本約爲58,602美元。
- 發生了什麼：3月7日，Oncternal Therapeutics公佈了樂觀的季度銷售額。
- Oncternal Therapeutics做什麼：Oncternal Therapeutics Inc是一家處於臨床階段的腫瘤學公司，正在開發一流的新型療法，這些療法針對的是醫療需求尚未得到滿足的各種癌症。
Don't forget to check out our premarket coverage here
別忘了在這裏查看我們的上市前報道
Westlake Chemical Partners
西湖化學合作伙伴
- The Trade: Westlake Chemical Partners LP (NYSE:WLKP) SVP, Olefin Material & Corp Pr Andrew Kenner bought a total of 5,000 shares at an average price of $22.23. To acquire these shares, it cost around $111,150.
- What's Happening: On Feb. 20, Westlake Chemical posted downbeat quarterly results.
- What Westlake Chemical Partners Does: Westlake Chemical Partners LP is a part of the chemical industry in the United States.
- 貿易：Westlake Chemical Partners LP（紐約證券交易所代碼：WLKP）烯烴材料公司高級副總裁安德魯·肯納 共購買了 5,000 股股票 平均價格爲22.23美元。收購這些股票的成本約爲111,150美元。
- 發生了什麼：2月20日，西湖化學公佈了悲觀的季度業績。
- Westlake Chemical Partners的所作所爲：Westlake Chemical Partners LP是美國化工行業的一部分。